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ABSTRACT: Biodegradable polymers (biopolymers) represent materials of new generation with application in
different areas of human activity. Their production has recently reached a commercial level. They can be divided
according to the origin (natural and synthetic), according to the chemical composition, methods of obtaining, ap-
plication etc. The use of biopolymers in medicine depends on their biocompatibility, mechanical resistance, and
sorptive characteristics. Today, they are the most commonly used as implants in vascular and orthopedic surgery,
for the production of materials such as catheters, products for gynaecology and haemodialysis, tooth reconstruc-
tion, etc. In pharmacy, they are used as a medicine matrix-carrier to allow controlled release of drug within the
body. Within this review paper, the properties and methods of production of certain biopolymers such as polygly-
colic acid (PGA), polylactide acid (PLA), poly-ε-coprolactone (PCL) and polybutylene succinate (PBS) will be de-
scribed in detail, as well as their application in medicine and pharmacy.
KEYWORDS: polyglycolic acid (PGA), polylactide acid (PLA), poly-ε-coprolactone (PCL), polybutylene succi-
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INTRODUCTION
A biomaterial is defined as any natural or syn-
thetic substance engineered to interact with biological
systems to direct medical treatment.
Biomaterials must be biocompatible meaning that
they perform their function with an appropriate host
response [1]. Biodegradable polymers comprise ester,
amide, or ether chemical bonds. In general, biode-
gradable polymers can be grouped into two large
groups on basis of their structure and synthesis. One
of these groups is agro-polymers, i.e. those derived
from biomass. The other consists of bio polyesters,
which are those derived from microorganisms or syn-
thetically made from either naturally or synthetic
monomers [2].
Figure 1. Classification of the main biodegradable polymers [3]
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Biodegradable polymers represent a growing
field. A vast number of biodegradable polymers (e.g.
cellulose, chitin, starch, polyhydroxyalkanoates,
polylactide, polycaprolactone, collagen and other
polypeptides) have been synthesized or are formed in
a natural environment during the growth cycles of
organisms. Some microorganisms and enzymes ca-
pable of degrading such polymers have been identi-
fied. There are different classifications of biodegrad-
able polymers, hereby is presented the classification
according to the synthesis process, which is shown in
Figure 1.
Polyesters are among the most used biodegrad-
able plastics, given their hydrolysable ester bonds;
therefore they represent a valid solution for biomedi-
cal applications. The properties of these materials
strictly depend on the monomers used for their syn-
thesis.
The aliphatic polyesters are almost the only high
molecular weight biodegradable compounds and thus
have been extensively investigated. Their hydroly-
sable ester bonds make them biodegradable. Ali-
phatic polyesters can be classified into two types ac-
cording to the bonding of the constituent monomers.
The first class consists of the polyhydroxy-
alkanoates. These are polymers synthesized from hy-
droxyacids, HO-R-COOH.
Examples are poly(glycolic acid) or poly(lactic
acid). Poly(alkene dicarboxylate)s represent the sec-
ond class. They are prepared by polycondensation of
diols and dicarboxylic acids. Examples are
poly(butylene succinate) and poly(ethylene succi-
nate) [4]. Application of biomaterials in therapy are
various and some of these applications are aimed at
replacing a lost function or an organ and request a
therapeutic device made of biomaterials (prosthesis)
for the rest of the patient's lifetime. Many other bio-
medical applications require a therapeutic aid for a
limited period of time. Accordingly, it is desirable
that the temporary therapeutic aid disappear from the
body after healing in order to avoid the storage of any
foreign materials.
Whereas permanent aids require biostable bioma-
terials, temporary aids should be preferably made of
degradable or biodegradable compounds that can be
eliminated from the body or to be bioassimilated after
use.
Historically, biopolymers, i.e. polymers of natu-
ral origin such as polysaccharides and proteins, were
primarily used as sources of wound dressings and
suture threads either under their natural forms or after
some chemical treatments. Because macromolecular
compounds are usually biodegradable, i.e. degraded
via biological processes, biopolymers are often re-
garded as suitable compounds to make bioresorbable
therapeutic devices [5]. Biodegradable polymers that
are often used as biomaterials are shown in Figure 2.
Figure 2. Biodegradable polymers used as biomaterials in hu-
man organism [7]
To be used as biomaterials, biodegradable poly-
mers should have three important properties: bio-
compatibility, bioabsorbility and mechanical resis-
tance. The use of enzymatically degradable natural
polymers, as proteins or polysaccharides, in biomedi-
cal applications began thousands of years ago,
whereas the application of synthetic biodegradable
polymers dates back some fifty years. Current appli-
cations of biodegradable polymers include surgical
implants in vascular or orthopaedic surgery and plain
membranes. Biodegradable polyesters are widely
employed as a porous structure in tissue engineering
because they typically have good strength and an ad-
justable degradation speed [4]. Biodegradable poly-
mers are also used as implantable matrices for the
controlled release of drugs inside the body or as ab-
sorbable sutures [6].
SYNTHESIS, PROPERTIES AND APPLICATIONOF
SOME BIODEGRADABLE POLYMERS
Properties and methods of production of most com-
mon biopolymers polyglycolic acid (PGA), polylac-
tide acid (PLA), poly-ε-coprolactone (PCL) and
polybutylene succinate (PBS) are described, as well
as their application in medicine and pharmacy.
POLYGLYCOLIC ACID (PGA)
Polyglycolide or polyglycolic acid (PGA) is a
biodegradable, thermoplastic polymer and the sim-
plest linear, aliphatic polyester (Figure 3). PGA has
been known since 1954 as a tough fiber-forming
polymer [8]. Polyglycolide has a glass transition
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temperature between 35-40°C and its melting point is
reported to be in the range of 225-230°C. PGA also
exhibits an elevated degree of crystallinity, around
45-55%, thus resulting in insolubility in water. The
solubility of this polyester is somewhat unique, in
that its high molecular weight form is insoluble in
almost all common organic solvents (acetone, di-
chloromethane, chloroform, ethyl acetate, tetrahydro-
furan), while low molecular weight oligomers suffi-
ciently differ in their physical properties to be more
soluble. However, polyglycolide is soluble in highly
fluorinated solvents like hexafluoroisopropanol
(HFIP) and hexafluoroacetone sesquihydrate that can
be used to prepare solutions of the high molecular
weight polymer for melt spinning and film prepara-
tion. Fibers of PGA exhibit high strength and






Figure 3. PGA structure
Synthesis. Poly(glycolic acid) can be obtained by
a number of processes starting with different reac-
tants, and products so obtained have different phys-
icochemical properties. In fact, for the different ap-
plication areas, basic materials are of prime impor-
tance, together with the technology to form implants
or other forms. For instance, in the orthopaedic field,
mechanical properties and design of the end product
will be essential; to a lesser extent this will be the
case in the pharmaceutical field, and so less attention
needs to be paid to these aspects [10]. PGA can be
obtained through several different processes starting
with different materials: polycondensation of glycolic
acid, ring-opening polymerization of glycolide and
solid-state polycondensation of halogenoacetates.
Polycondensation of glycolic acid is the simplest
process available to prepare PGA, but it is not the
most efficient because it yields a low molecular
weight product. The most common synthesis used to
produce a high molecular weight form of the polymer
is ring-opening polymerization of "glycolide", the
















Figure 4. Ring-opening polymerization of glycolid In spite of its low solubility, this polymer has been fabricated into a variety of forms and
structures. Extrusion, injection and compression molding as well as particulate leaching and solvent casting, are some of the techniques
used to develop polyglycolide-based structures for biomedical applications. The high rate of degradation, acidic degradation products and
low solubility however, limit the biomedical applications for PGA.
Therefore, several copolymers containing gly-
colide units are being developed to overcome the in-
herent disadvantages of PGA. Due to its hydrophilic
nature, surgical sutures made of PGA tend to lose
their mechanical strength rapidly, typically over a
period of two to four weeks post-implantation. In
order to adapt the materials properties of PGA to a
wider range of possible applications, researchers un-
dertook an intensive investi-gation of copolymers of
PGA with the more hydrophobic PLA.
Polycondensation of glycolic acid is the simplest
process available to prepare PGA, but it is not the
most efficient one because it yields a low molecular
weight product [11]. Briefly, the procedure is as fol-
lows: glycolic acid is heated at atmospheric pressure
and a temperature of about 175–185°C is maintained
until water ceases to distill. Subsequently, pressure is
reduced to 150 mm Hg, still keeping the temperature
unchanged for about two hours and the low molecu-
lar weight poly(glycolic acid) is obtained. The poly-
mer obtained has a low molecular weight, because it
is hard to remove water completely from the highly
viscous reaction mixture; therefore a polymer of a
molecular weight of a few ten thousands is obtained.
In the polycondensation system of PGA, two princi-
pal equilibrium exist, one is dehydration equilibrium
for esterification [12]. The cationic-ring opening po-
lymerization reaction of lactones has been achieved
using alkylating agents, acylating agents, Lewis ac-
ids, and protic acids.
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However, the quality of end product varies with
the agents used. There are reports that polymers pre-
pared using protic acid such as sulphuric acid and
phosphoric, yield brittle and highly coloured poly-
mers in high yield. While the polymers prepared us-
ing Lewis acids such as zinc chloride, ferric chloride,
aluminium chloride, titanium tetrachloride, boron
triflouride etherate, and antimony triflouride yield
high molecular weight and high tensile strength PGA,
especially antimony triflouride gave a tough and col-
ourless almost quantitatively, whose reduced viscos-
ity was higher than 0.7 [13]. Boron triflouride was
moderately active at low temperature of 110°C.
Chemical and physical properties. Polyglycolide
has a glass transition temperature between 35-40°C
and its melting point is reported to be in the range of
225-230°C. PGA also exhibits an elevated degree of
crystallinity, around 45-55%, thus resulting in in-
solubility in water [11].
PGA can be easily crystallized as spherulites and
hedrites in a hedritic rosette. Braided sutures from
melt-extruded, stretched, and heat-set PGA fibres
were chosen for their high strength, excellent han-
dling properties, minimal tissue reactivity, and a
similar but more reproducible absorption rate than
catgut, as comparing to nylon-4, poly(β-
hydroxybutyric acid), poly(ethylene oxide), oxidized
regenerated cellulose, and poly(vinyl alcohol) as ab-
sorbable sutures [14].
However, one of the two PGA polymorphs from
ring-opening polymerization is readily degradable in
the presence of moisture. In 1973, using the thermo-
gravimetric gas evolution analysis together with ki-
netic study, It was confirmed that degradation of
PGA was a first-order reaction mainly via an in-
tramolecular ester interchange mechanism, as shown


















Figure 5. Intramolecular ester interchange mechanism of poly(glycolide) degradation
(the intramolecular arrow indicates the direction in which the ester interchange occurs)
Application. Polyglycolide and its copolymers
poly(lactic-co-glycolic acid) (PLA–PGA),
poly(glycolide-co-caprolactone) and poly(glycolide-
co-trimethylene carbonate) are widely used as mate-
rials for the synthesis of absorbable sutures. In most
cases, PGA is copolymerized with other organic ac-
ids such as with PLA to make a PLA–PGA copoly-
mer for improving its property. PGA–PLA copoly-
mers have been known to be biodegradable and his-
tocompatible for the past 40 years. Their physico-
chemical and biological properties have been found
suitable, in many instances, for sustaining drug re-
lease in vivo for days or months. Microencapsulation
technique is chosen frequently for its unique proper-
ties because microcapsules can be made using differ-
ent traditional and nontraditional techniques contain-
ing core materials ranging from biological proteins to
synthetic drugs. A biocompatible delivery system
using poly(-DLlactide-co-glycolide) microspheres
was developed as a controlled release antigen for
parenteral administration. It offers several advantages
in terms of immune adjuvanticity over other com-
pounds. In contrast to other carriers, microspheres are
more stable, thus permitting administration by the
oral or parenteral route [14]. Because of PGA’s rapid
degradation and insolubility in many common sol-
vents, limited research has been conducted with
PGA-based drug delivery devices. Instead, the most
recent research has focused on short-term tissue en-
gineering scaffolds and the utilization of PGA as a
filler material coupled with other degradable polymer
networks [1].
PGA is often fabricated into a mesh network and
has been used as a scaffold for bone, cartilage, ten-
don, tooth, vaginal, intestinal, lymphatic, and spinal
regeneration. Although there has been research con-
ducted into a wide range of applications, there exist
significant issues with PGA. Rapid degradation leads
to the loss of mechanical strength and significant lo-
cal production of glycolic acid. Although glycolic
acid is bioresorbable by cells via the citric acid cycle,
high level of glycolic acid have been linked to a
strong, undesired inflammatory response. In addition,
PGA has mechanically failed as a biomaterial when
used to facilitate colonic anastomosis formation and
prevent intrapericardial adhesions [1].
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POLYLACTIC ACID (PLA)
Polylactic acid or polylactide (PLA) is a biode-
gradable thermoplastic aliphatic polyester derived
from renewable resources (corn starch, cassiva roots,
sugarcane etc.). PLA is the most consumed biopoly-
mer in the world (Figure 6) [15]. Polylactic acid be-
longs to the family of aliphatic polyesters commonly
made from α-hydroxy acids, which include polygly-
colic acid or polymandelic acid, and are considered
biodegradable and compostable. PLA was discovered
in 1932 by Carothers (at DuPont). He produced a
low molecular weight PLA by heating lactic acid un-
der vacuum while removing condensed water. By
ring-opening polymerization of the lactide, high-
molecular PLA was synthesized. PLA was first used
in combination with polyglycolic acid (PGA) and





Figure 6. PLA structure
Synthesis. The basic building block for PLA is
lactic acid, which was first isolated in 1780 from sour
milk by the Swedish chemist Scheele and first com-
mercially produced in 1881 [17]. The production of
PLA is a multistep process which starts from the pro-
duction of lactic acid, (2-hydroxy propionic acid), as
single monomer of PLA, which is produced via fer-
mentation or chemical synthesis and -ends with its
polymerization. An intermediate step is often the
formation of lactide. Polymerization of lactic acid
can follow three main routes: direct condensation
polymerization, direct polycondensation in an
azeotropic solution and polymerization through lac-
tide formation. Lactic acid can be manufactured ei-
ther by carbohydrate fermentation or chemical syn-
thesis, although fermentation predominates [18]. The
majority of the world,s commercially produced lactic
acid is made by bacterial fermentation of carbohy-
drates, using homolactic organisms such as various
optimized or modified strains of the genus Lactoba-
cilli, which exclusively form lactic acid. The organ-
isms that predominantly yield the L(+)-isomer are
Lactobacilli amylophilus, L. bavaricus, L. casei, L.
maltaromicus and L. salivarius [17].
These strains yield high carbon conversions from
feed stocks at standard fermentation conditions, pH
range of 5.4 to 6.4, a temperature range of 38 to 42
°C, and a low oxygen concentration. The various
types of carbohydrates that can be utilized in the fer-
mentation depend on the particular strain of Lactoba-
cillus. Most of the simple sugars obtained from agri-
cultural byproducts can be used. These sugars in-
clude: glucose, maltose and dextrose from corn or
potato starch; sucrose from cane or beet sugar and
lactose from cheese whey.
Commercial fermentation is usually conducted in
a batch process. Sugar concentrations of 5-10% are
used, with the production rates of 2 grams of acid per
1 litre of broth per hour. Various methods of extrac-
tion of the produced acid have been developed. The
major method of separation is based on calcium hy-
droxide addition to neutralize the fermentation acid
and give soluble calcium lactate solutions, which is
recrystallized and purified to give crude lactic acid.
Direct condensation polymerisation of lactic acid
yields low-molecular-weight glassy polymer which is
unusable for any application unless external coupling
agents are used to increase the molecular weight of
the polymer. Producing high molecular weight PLA
polymers by direct polycondensation in an azeotropic
solution application of catalysts is more efficient. The
choice of catalysts and solvent volume percentages
enabled the higher molecular weights of PLA up to
6.6 x 104 [19]. The third mechanism of producing
PLA is to purify and ring-open polymerize (ROP)
lactide to yield high-weight-average molecular






















Figure 7. Synthesis of poly(lactide) (PLA)
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The lactide method was the only method of pro-
ducing pure, high-molecular-weight PLA until Mitsui
Toatsu Chemicals commercialized the catalytic po-
lymerization process in aprotic solvent, i.e.,
azeotropic dehydration condensation and obtained
PLA with average molecular weights greater than
300.000 [20]. To increase the molecular weight,
chain-coupling agents must be added, and it will
preferentially react with either the hydroxyl or car-
boxyl groups. The condensed PLA can be modified
to produce either all hydroxyl or all carboxyl groups.
The PLA can also be treated with anhydrides such as
maleic or succinic to convert the hydroxyl to a car-
boxylic end-group [21]. Various esterification–
promoting adjuvants and chain-extending agents
have been reported that can be used to increase the
molecular weight of the PLA condensation products
[22]. The use of chain-extending agents overcomes
many of the disadvantages associated with esterifica-
tion – promoting adjuvents. The azeotropic conden-
sation polymerization is a method to obtain high-
molecular-weight polymer without the use of chain
extenders or adjuvents. The ring-opening polymeriza-
tion of lactide was first demonstrated by Carothers in
1932, but high molecular weights were not obtained
until improved lactide purification techniques were
developed by Du Pont in 1954 [23]. Polymerization
through lactide formation is being industrially ac-
complished for high molecular weight PLA produc-
tion. Ring-opening polymerization of lactide can be
carried out in melt or solution by cationic, anionic
and coordination mechanisms, depending on the ini-
tiator utilized. The most considered active initiator
for the L-lactide ring–opening polymerization is
stannous octoate (bis-2-ethyl hexanoate, SnOct2),which causes a low degree of racemization at high
temperature. The choice of initiator system, co-
initiator as chain control agent, catalyst concentra-
tion, monomer-to-initiator ratio, and polymerization
temperature and time significantly affect the polymer
properties. Properties such as molecular weight, de-
gree of crystallinity, and residual monomer content,
in turn affect the psychico-mechanical properties of
polylactide and its copolymers [24].
Chemical and physical properties. Poly(lactic
acid) exists as a polymeric helix, with an orthorombic
unit cell. Due to chiral nature of lactic acid, several
forms of polylactide exist. PLA is soluble in chlorin-
ated solvents, such as benzene, tetrahydrofuran and
dioxane [22]. The tensile properties of PLA can vary
widely, depending on whether or not it is annealed or
oriented or what its degree of crystallinity is. Polyac-
tic acid can be processed into fibre and film on stan-
dard plastics equipment. PLA undergoes thermal
degradation at temperatures above 200oC by hydroly-
sis, lactide reformation, oxidative main chain scis-
sion, and inter- or intramolecular transesterification
reactions. PLA degradation is dependent on time,
temperature, low-molecular-weight impurities and
catalyst concentration [25]. Catalysts and oligomers
decrease the degradation temperature and increase
the degradation rate of PLA. Poly(lactic) homopoly-
mers have a glass-transition and a melt temperature
of about 55°C and 175°C, respectively. PLA have a
very narrow processing window. The most widely
used method for improving PLA processability is
based on melting point depression by the random
incorporation of small amounts of lactide enanti-
omers of opposite configuration into the polymer
(i.e., adding a small amount of D-lactide to the L-
lactide) [26]. High-molecular-weight poly(lactic
acid) is a colourless, glossy, stiff thermoplastic
polymer with properties similar to polystyrene. The
amorphous PLA is soluble in most organic solvents
(tetrahydrofuran, THF), chlorinated solvents, ben-
zene, acetonitrile and dioxane [17].
Application. PLA has potential for use in a wide
range of applications. It is used as a buffering agent,
acidic flavouring agent, acidulant and bacterial in-
hibitor in many processed foods. PLA is growing
alternative as a „green“ food packaging polymer. Due
to the larger thermal processing ability compared to
other biomaterials like polyethylene-glycol, polyhy-
droxyalkanoates (PHA) and poly α-caprolactone; the
processing of PLA can be achieved by film casting,
extrusion, blow molding and fiber spinning [27]. The
major PLA application today is packaging (70%); the
estimation for 2020 shows the increase of other ap-
plications especially in biomedicine.
Commercialized PLA products demonstrate the
fact that PLA is not being used solely because of its
degradability, nor because it is made from renewable
resources; it is being used because it functions very
well and provides excellent properties at a competi-
tive price [28]. Applications of PLA are limited by
several factors such as low glass transition tempera-
ture, weak thermal stability and low toughness and
ductility [29].
A large number of investigations have been per-
formed on the blending of PLA with various poly-
mers, such as: thermoplastic starch, poly(ethylene
oxide), poly(ethylene glycol), poly(-caprolactone),
poly(vinyl acetate), poly(butylene succinate) etc.
Low molecular weight compounds have also been
used as plasticizers for PLA, for example, oligomeric
lactic acid, glycerol, low molecular citrates etc. [30].
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The choice of polymers or plasticizers that are to
be used as modifiers of PLA is limited by the re-
quirements of application. The final properties of
these blends depend on the chemical structure of the
original components, the mixing ratio of the constitu-
ent polymers, the interaction between the compo-
nents and the processing steps to which they are then
subjected. PLA is also used in biomedical applica-
tions, with various uses as internal body components,
interference screews in ankle, knee and hand; tacks
and pins for ligament attachment; rods and pins in
bone, plates and screews for craniomaxillofacial bone
fixation [31] and also for surgical sutures, implants
and drug delivery systems [32]. This is based on their
advantages over nondegradable biomaterials with
respect to long term biocompatibility. PLA offers
biodegradability, biocompatibility and thermoplastic
process ability, and it is used as surgical implant ma-
terial and drug delivery systems, as well as porous
scaffolds for the growth of neo-tissue [33]. Tissue
engineering is a technique whose concept was intro-
duced in 1988 by the reconstruction of the biological
tissues using biomaterials. Three dimensional porous
scaffolds of PLA have been created for culturing dif-
ferent cell types used in cell based gene therapy for
cardiovascular diseases, muscle tissues, bone and
cartilage regeneration [34].
Different surface modification strategies, such as
physical, chemical, plasma and radiation induced
methods for creating desirable surface properties of
PLA biomaterials. PLA fibres are used for ligament
and tendon reconstruction and stents for vascular and
urological surgery. One application of PLA in the
form of injectable microspheres is for temporary fill-
ings in facial reconstructive surgery, as well as em-
bolic material in trans catheter arterial embolization
[35].
Microspheres and microcapsules have been ap-
plied in drug delivery systems (DDS). Release of
drugs from these systems is based on several mecha-
nisms that include diffusion and polymer degradation
(hydrolysis or enzymatic degradation) [36]. Erosion,
diffusion and swelling are one of the ways by which
polymeric drug release occurs. In the encapsulation
process of many drugs, PLA and their copolymers
have been utilized in nanoparticle form [37]. Differ-
ent methods were used to obtain nano-particles, such
as solvent evaporation, solvent displacement, salting
out and emulsion solvent diffusion [38]. PLA nano
particles have been tested in human skin revealing
that they can propose the active sites into hair folli-
cles which makes them a stellar candidate as a drug
delivery layout [39].
Due to high strength it is possible to create 3D
structures for bone fixation in the forms of plates,
pins, screws and wires. Three dimensional (3D) elec-
trowave fibrous scaffolds is a possibility tissue engi-
neering device for bone renewal. PLA and its co-
polymers are utilized in wound management, such as
surgical sutures, healing dental extraction wounds
[40].
PLA can be blended with other monomers, such
as glycolic acid, and such copolymer is used in drug
release. PLA is often mixed with starch to increase
biodegradability and to reduce its price and to in-
crease the water absorption.
POLY (Ε-CAPROLACTONE) (PCL)
Poly ε-caprolactone, PCL is one of biodegradable
and biocompatible polymers, which have received
significant attention because they are environmen-
tally friendly and are extensively used in biomedical




Figure 8. PCL structure
Synthesis. Poly (ε-caprolactone) PCL is synthe-
sized by polymerization of hydroxy acids, HO-R-
COOH, or by ring-opening-polymerization of cyclic
monomers, -R-COO-. PCL is prepared by the ring
opening polymerisation of the cyclic monomer
(ROP) of ε-capro lactone (ε-CL) using ammonium
heptamolybdate as a catalyst at 155 °C. It is com-
posed of five methy lenes [(CH2)5] and an ester func-tional group as the repeating unit (Figure 9) and was
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Figure 9. Synthesis of poly(ε-caprolactone) (PCL)
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PCL and its derivatives are polymers that have
been of great interest in the pharmaceutical industry
as matrices for medical formulas. Recently a wide
range of catalysts for the ring opening polymerization
of caprolactone has been reviewed. Catalysts such as
stannous octoate are used to catalyze the polymeriza-
tion and low molecular weight alcohols can be used
to control the molecular weight of the polymer. There
are various mechanisms which affect the polymeriza-
tion of PCL and these are anionic, cationic, co-
ordination and radical. Each method affects the re-
sulting molecular weight, molecular weight distribu-
tion, end group composition and chemical structure
of the copolymers [41]. The obtained PCL was puri-
fied by dissolution into chloroform and precipitated
ion with methanol, finally being isolated by vacuum
filtration [42].
Chemical and physical properties. PCL is a semi-
crystalline aliphatic polymer that has a slow degrada-
tion rate 12-24 months. It has a low glass transition
temperature at -60°C, a melting temperature at about
60°C, and a high thermal stability [43]. PCL has been
shown to be degraded by the action of aerobic and
anaerobic microorganisms that are widely distributed
in various ecosystems [44]. The biodegradability of
PCL can be increased by copolymerization with ali-
phatic polyesters [45]. PCL is soluble in tetrahydro-
furan, chloroform, methylene chloride, carbon tetra-
chloride, benzene, toluene, cyclohexanone dihydro-
pyran and 2-nitropropane and only partially soluble
in acetone, 2-butanone, ethyl acetate, acetonitrile and
dimethyl fumarate [46]. Recently, other studies have
considered the fabrication of PCL nanofibres using
less harmful solvents, like formic acid. In fact, formic
acid is relevant for the reduction of the fibre diameter
[47]. PCL is degradable in several biotic environ-
ments, including river and lake waters, sewage
sludge, farm soil, paddy soil, creek sediment, road-
side sediment, pond sediment, and compost [48]. The
degradation times of PCL varies with molecular
weight, crystallinity degree and morphology [49].
Application. Due to PCL’s very low in vivo deg-
radation rate and high drug permeability, it has found
favour as a long-term implant delivery device. Cur-
rent research is being conducted into the develop-
ment of micro- and nano-sized drug delivery vehi-
cles, but the degradation rate (2–3 years) is a signifi-
cant issue for pure PCL products to be FDA ap-
proved for this use. PCL and PCL composites have
been used as tissue engineering scaffolds for regen-
eration of bone, ligament, cartilage, skin, nerve, and
vascular tissues [1]. A recent advancement using
PCL hybrid scaffolds has been used in interfacial
tissue engineering [1].
PCL nanofibres show viscoelastic properties. It
could be that higher molecular weight PCL results in
softer nanofibres. These different values suggest that
different nanofibre properties can be achieved by
varying the preparation methods. The mechanical
properties of electrospun PCL nanofibres do not
closely mimic any of the natural or electrospun pro-
tein fibres. However, they seem to come closer to
fibrin fibres and electrospun fibrinogen fibres, rather
than collagen fibres [50]. PCL fibres may have suit-
able mechanical properties for various applications in
biomedical and tissue engineering including blood
vessels, skin grafts, and tendons. Viscoelastic proper-
ties have been found to depend on the age of the fi-
bres. Younger fibres could be pulled to a greater
strain before permanent deformation than older fi-
bres. This is an important property for determining
how long a scaffold made from these single fibres
can be stored before the mechanical properties are
significantly altered. The relaxation times and total
and elastic moduli also show age-relate dependen-
cies. This dependence on age gives a better under-
standing of how PCL degrades over time, from a me-
chanical perspective. Combining these findings with
PCL's bioresorbable properties will allow for better
fabrication of specific bioengineered scaffolds and
devices [50].
POLY(BUTYLENE SUCCINATE), PBS
Polycaprolactone (PCL), and poly(butylene suc-
cinate) (PBS) are petroleum based, but they can be
degraded by microorganisms. PBS degrading micro-
organisms are widely distributed in the environment,
but their ratio to the total microorganisms is lower







Figure 10. PBS structure
PBS is nowadays one of the most appealing bio-
degradable polymer because it is fully sustainable,
commercially available and exhibits a good balance
of thermal and mechanical properties [51]. PBS also
referred to as polytetramethylene succinate, is a bio-
degradable thermoplastic polyester resin. PBS exhib-
its good thermal and mechanical properties that are
comparable with those of widely used polymers such
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as polyethylene and polypropylene, with high melt-
ing points of 112-114 °C. The favourable properties
coupled with ease of processing have resulted in
emergence of a variety of application areas across
diverse end use industries for PBS. Efforts are chan-
nelized towards developing bio-based PBS from bio
based 1,4 butanediol and succinic acid. Succinic acid
is one of the two primary intermediates used to
manufacture PBS, and is a building block chemical in
the production of 1,4-butanediol (BDO). Although
diglycollic acid has a similar structure to succinic
acid, it possesses ether-oxygen in molecules and thus,
thermal, mechanical and biodegradable properties are
different [52]. Biodegradable plastic like PBS has
conventionally been made using petroleum-based
feedstock but it moved the packaging industry a step
in the right environmental direction. Mechanical
properties are comparable to polypropylene and low-
density polyethylene (LDPE) [44]. PBS is synthe-
sized from dicarboxylic acids (e.g., succinic and
adipic acid) and glycols (e.g., ethylene glycol and
1,4-butanediol) [53]. Synthesis of PBS is presented in
Figure 11.







Figure 11. Synthesis of PBS
It has high flexibility, excellent impact strength,
and thermal and chemical resistance. However, its
high cost and other properties such as elastic
modulus, tensile strength, gas barrier properties, and
melt viscosity for further processing, restrict its ex-
tensive application [54].
CONCLUSIONS
Biodegradable polyesters have been intensively
investigated in the last two decades because of their
biodegradability and superb physical properties. The
biodegradable polymers are indispensable in drug
delivery due to their unrivalled physicochemical
properties. These physicochemical properties have a
significant effect on the drug delivery system, as well
as on the pharmacological effect. Currently, a wide
range of degradable polymers exist that hold poten-
tial as biomaterials. As a result, the market of these
environmentally friendly materials is in rapid expan-
sion. Utilization of polymers as biomaterials has
greatly impacted the advancement of medicine and
pharmacy. Biopolymers with desired physical,
chemical, biological, biochemical and degradation
properties can be designed, and a wide range of these
novel materials have been investigated for biomedi-
cal applications. The field of degradable polymeric
biomaterials will continue to progress since these
new materials present the great challenge to sophisti-
cated multidisciplinary research as well as to their
economic technological production.
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